Oxford researchers, supported by the Medical Research Council, are developing personalized cancer vaccines using AI, leveraging one of the UK's most powerful supercomputers, Dawn.
The team is using the DAWN supercomputer for research
Jun 03, 2026
01:11 pm
What's the storyOxford University has secured fresh funding to develop personalized cancer vaccines using artificial intelligence (AI).
The team is leveraging advanced technologies such as the DAWN supercomputer to analyze vast amounts of cancer and immune data.
World's first AI-designed vaccine developed by UK scientists enters human trials
First-ever AI-designed vaccine reaches human trials
Cambridge scientists test AI-designed vaccine on humans
Researchers Are Using AI to Create Vaccines—and It's Working
Scientists design first ‘universal vaccine’ with the help of AI
Scientists develop vaccine using AI that could prevent future pandemics
First AI-designed 'universal vaccine' tested in humans: UK researchers - The Economic Times
Vaccini e AI, a Cambridge il primo test umano di un componente creato completamente dall’algoritmo
Voor het eerst vaccin ontwikkeld met kunstmatige intelligentie
Can AI stop the next pandemic? Scientists unveil vaccine breakthrough
Researchers at the University of Oxford will have 10,000 hours of access to the device.
A vaccine designed with the help of artificial intelligence has entered human trials in what scientists are calling a world-first…
Researchers at the University of Cambridge have developed the first-ever vaccine component designed entirely by artificial…
Targets entire family of viruses, animal-borne strains; aims to thwart future pandemics; initial-phase trials of 39 participants…
Cambridge scientists have successfully completed the first human trial of an AI-designed universal coronavirus vaccine, aiming to…
pEVAC-PS is the first experimental vaccine designed completely with AI to be tested in a human trial.
